Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
✍ Scribed by Krentz, S; Hof, J; Mendioroz, A; Vaggopoulou, R; Dörge, P; Lottaz, C; Engelmann, J C; Groeneveld, T W L; Körner, G; Seeger, K; Hagemeier, C; Henze, G; Eckert, C; von Stackelberg, A; Kirschner-Schwabe, R
- Book ID
- 111889456
- Publisher
- Nature Publishing Group
- Year
- 2012
- Tongue
- English
- Weight
- 888 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Of 54 children with acute lymphoblastic leukemia (ALL) and first hematological recurrence observed between 1985 and 1989, 31 relapsed while still on treatment and 23 after cessation of therapy. Of the former, only one survived. Of the latter, 11 children survived after a minimum follow‐
The outcome of children with acute lymphoblastic leukemia (ALL) and bone marrow relapse has been unsatisfactory largely because of failure to prevent subsequent leukemia relapses. Ninety-six patients were enrolled and received vincristine, prednisone, L-asparaginase, and an anthracycline as reinduc